In tandem with methotrexate, the drug is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis. Availability across EEA markets will progress in line ...

New research could allow health care providers to identify and treat patients at risk for rheumatoid arthritis before the ...

The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, ...

Rheumatoid arthritis (RA) is a common autoimmune disease where the body's immune system mistakenly attacks the lining of its own joints, causing chronic pain, swelling, and stiffness. While there have ...

The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, ...

Water-based therapies can help with joint stiffness, pain, and limited mobility, offering relaxation and low-impact exercise.

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost management strategies.

Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes inflammation throughout the body and most often affects the joints, leading to pain, stiffness, swelling, and reduced mobility.

Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with ...

Could SGLT2 Inhibitors Reduce Rheumatoid Arthritis Flares? Two ACR 2025 analyses link SGLT2 inhibitors to fewer RA flares and a lower risk for osteoarthritis than GLP-1 receptor agonists, though ...

Osteoarthritis develops from joint tissue wearing down over time, while rheumatoid arthritis involves the immune system. Some types of arthritis can be hereditary, including ankylosing spondylitis.